20
Views
76
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of Interferon Therapy in Patients with Chronic Hepatitis C: Comparison between Non-Drinkers and Drinkers

, , , , , , & show all
Pages 1039-1043 | Received 20 Nov 1993, Accepted 22 Feb 1994, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jessica E. Hoyt, Nikhil Teja, Tammy Jiang, Luke Rozema, Jiang Gui, Bradley V. Watts, Brian Shiner & Jaimie L. Gradus. (2022) Changes in Alcohol Consumption following Direct-Acting Antiviral Treatment for Hepatitis C in VA Patients with Comorbid Alcohol Use Disorder and PTSD. Journal of Dual Diagnosis 18:4, pages 185-198.
Read now
Manuela G. Neuman, Maristela Monteiro & Jürgen Rehm. (2006) Drug Interactions Between Psychoactive Substances and Antiretroviral Therapy in Individuals Infected With Human Immunodeficiency and Hepatitis Viruses. Substance Use & Misuse 41:10-12, pages 1395-1463.
Read now
Adeel A Butt. (2005) Hepatitis C virus infection: the new global epidemic. Expert Review of Anti-infective Therapy 3:2, pages 241-249.
Read now
ClarkC. Kulig & ThomasP. Beresford. (2005) Hepatitis C in Alcohol Dependence. Journal of Addictive Diseases 24:2, pages 77-89.
Read now

Articles from other publishers (72)

Chisom IA Okwor, Yelena Petrosyan, Craig Lee & Curtis Cooper. (2022) History of alcohol use does not predict HCV direct acting antiviral treatment outcomes. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada.
Crossref
Matt Driedger, Marie-Louise Vachon, Alexander Wong, Brian Conway, Alnoor Ramji, Sergio Borgia, Ed Tam, Lisa Barrett, Dan Smyth, Jordan J Feld, Sam S Lee & Curtis Cooper. (2021) Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis. Canadian Liver Journal 4:3, pages 283-291.
Crossref
Nicole J. Kim, Meredith Pearson, Philip Vutien, Feng Su, Andrew M. Moon, Kristin Berry, Pamela K. Green, Emily C. Williams & George N. Ioannou. (2020) Alcohol Use and Long‐Term Outcomes Among U.S. Veterans Who Received Direct‐Acting Antivirals for Hepatitis C Treatment. Hepatology Communications 4:2, pages 314-324.
Crossref
Douglas N. Fish. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions 381 424 .
Andréa Carvalho Maia VIEIRA-CASTRO & Luiz Carlos Marques de OLIVEIRA. (2017) Impact of alcohol consumption among patients in hepatitis C virus treatment. Arquivos de Gastroenterologia 54:3, pages 232-237.
Crossref
Elizabeth Chereji, Shira Kern, Bret Fuller, Benjamin J. Morasco, Alissa Phelps & Peter Hauser. (2016) Co-occurring Depression, Chronic Pain and Substance Use Disorders in People with Hepatitis C. Open Medicine Journal 3:1, pages 79-103.
Crossref
Daniel Fuster, Arantza Sanvisens, Ferran Bolao, Inmaculada Rivas, Jordi Tor & Robert Muga. (2016) Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World Journal of Hepatology 8:31, pages 1295.
Crossref
Ignacio Novo-Veleiro. (2016) Alcoholic liver disease and hepatitis C virus infection. World Journal of Gastroenterology 22:4, pages 1411.
Crossref
Ching-Chung Lin, Chia-Hsien Wu, Huan-Lin Chen, I-Tsung Lin, Ming-Jen Chen, Tsang-En Wang, Horng-Yuan Wang, Shou-Chuan Shih & Ming-Jong Bair. (2015) Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan. Journal of the Formosan Medical Association 114:11, pages 1069-1075.
Crossref
Natalia Osna, Murali Ganesan & Kusum Kharbanda. (2015) Hepatitis C, Innate Immunity and Alcohol: Friends or Foes?. Biomolecules 5:1, pages 76-94.
Crossref
Ignacio Novo-Veleiro, Cristina de la Calle, Susana Domínguez-Quibén, Isabel Pastor, Miguel Marcos & Francisco-Javier Laso. (2013) Prevalence of Hepatitis C Virus Infection in Alcoholic Patients: Cohort Study and Systematic Review. Alcohol and Alcoholism 48:5, pages 564-569.
Crossref
Victoria A. Sublette, Mark W. Douglas, Kirsten McCaffery, Jacob George & Kathryn Nicholson Perry. (2013) Psychological, lifestyle and social predictors of hepatitis C treatment response: a systematic review. Liver International 33:6, pages 894-903.
Crossref
Charlotte E. Costentin, Jean-Baptiste Trabut, Vincent Mallet, Stéphane Darbeda, Véronique Thépot, Bertrand Nalpas, Béatrice Badin de Montjoye, Béatrice Lavielle, Anaïs Vallet-Pichard, Philippe Sogni & Stanislas Pol. (2013) Management of Hepatitis C Virus Infection in Heavy Drinkers. Alcohol and Alcoholism 48:3, pages 337-342.
Crossref
Angela C. Kim, Marcia E. Epstein, Pranisha Gautam-Goyal & Thien-Ly Doan. (2012) Infections in Alcoholic Liver Disease. Clinics in Liver Disease 16:4, pages 783-803.
Crossref
Marcia Russell, Mary Patricia Pauly, Charles Denton Moore, Constance Chia, Jennifer Dorrell, Renee J. Cunanan, Gayle Witt & Scott Martin. (2012) The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan. Hepatology 56:4, pages 1223-1230.
Crossref
Rae Jean Proeschold-Bell, Ashwin A. Patkar, Susanna Naggie, Lesleyjill Coward, Paolo Mannelli, Jia Yao, Patricia Bixby & Andrew J. Muir. (2011) An Integrated Alcohol Abuse and Medical Treatment Model for Patients with Hepatitis C. Digestive Diseases and Sciences 57:4, pages 1083-1091.
Crossref
Srinivasan Dasarathy & Arthur J. McCullough. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver 657 702 .
Douglas N. Fish. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases 471 508 .
Eric Dieperink, Samuel B. Ho, Sara Heit, Janet M. Durfee, Paul Thuras & Mark L. Willenbring. (2010) Significant Reductions in Drinking Following Brief Alcohol Treatment Provided in a Hepatitis C Clinic. Psychosomatics 51:2, pages 149-156.
Crossref
Abdel-Rahman El-Zayadi. (2009) Hepatitis C comorbidities affecting the course and response to therapy. World Journal of Gastroenterology 15:40, pages 4993.
Crossref
Jean-Philippe Lang, Laurent Michel, Michel Burger, Faredj Cherikh, Jean-Marie Lang & Michel Doffoel. 2009. Psychiatrie, VIH et hépatite C. Psychiatrie, VIH et hépatite C 123 129 .
Faredj Cherikh, Dominique Pringuey & Albert Tran. 2009. Psychiatrie, VIH et hépatite C. Psychiatrie, VIH et hépatite C 93 100 .
Oxana Norkina, Angela Dolganiuc, Donna Catalano, Karen Kodys, Pranoti Mandrekar, Amber Syed, Marian Efros & Gyongyi Szabo. (2008) Acute Alcohol Intake Induces SOCS1 and SOCS3 and Inhibits Cytokine-Induced STAT1 and STAT3 Signaling in Human Monocytes. Alcoholism: Clinical and Experimental Research 32:9, pages 1565-1573.
Crossref
Marilyn S Huckans, Jennifer M Loftis, Aaron D Blackwell, Alex Linke & Peter Hauser. (2007) Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders. Substance Abuse Treatment, Prevention, and Policy 2:1.
Crossref
Ashwani K. Singal & Bhupinder S. Anand. (2007) Mechanisms of Synergy Between Alcohol and Hepatitis C Virus. Journal of Clinical Gastroenterology 41:8, pages 761-772.
Crossref
Tom Nguyen, M. Mazen Jamal & Timothy R. Morgan. (2009) Alcohol abuse and chronic hepatitis C. Current Hepatitis Reports 6:3, pages 119-124.
Crossref
Alison A. Moore, Elizabeth J. Whiteman & Katherine T. Ward. (2007) Risks of combined alcohol/medication use in older adults. The American Journal of Geriatric Pharmacotherapy 5:1, pages 64-74.
Crossref
Chiung M. Chen, Young‐Hee Yoon, Hsiao‐ye Yi & Diane L. Lucas. (2007) Alcohol and Hepatitis C Mortality Among Males and Females in the United States: A Life Table Analysis. Alcoholism: Clinical and Experimental Research 31:2, pages 285-292.
Crossref
Stanislas Pol & Marc Bourlière. (2006) Optimizing Treatment Outcomes in Chronic Hepatitis C: Management of Non-Response. Antiviral Therapy 11:8, pages 955-970.
Crossref
David Nunes, Richard Saitz, Howard Libman, Debbie M. Cheng, John Vidaver & Jeffrey H. Samet. (2006) Barriers to Treatment of Hepatitis C in HIV/HCV-Coinfected Adults with Alcohol Problems. Alcoholism: Clinical and Experimental Research 30:9, pages 1520-1526.
Crossref
Ting Zhang, Yuan Li & Wen‐Zhe Ho. (2006) Drug abuse, innate immunity and hepatitis C virus. Reviews in Medical Virology 16:5, pages 311-327.
Crossref
Bhupinder S. Anand, Sue Currie, Eric Dieperink, Edmund J. Bini, Hui Shen, Samuel B. Ho & Teresa Wright. (2006) Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study. Gastroenterology 130:6, pages 1607-1616.
Crossref
Jules L. Dienstag & John G. McHutchison. (2006) American Gastroenterological Association Technical Review on the Management of Hepatitis C. Gastroenterology 130:1, pages 231-264.
Crossref
Pierre Lahmek & Stéphane Nahon. (2006) Alcool et virus C. EMC - Hépatologie 1:1, pages 1-4.
Crossref
Sripriya Balasubramanian & Kris V. Kowdley. (2005) Effect of Alcohol on Viral Hepatitis and Other Forms of Liver Dysfunction. Clinics in Liver Disease 9:1, pages 83-101.
Crossref
J Westin. 2005. Comprehensive Handbook of Alcohol Related Pathology. Comprehensive Handbook of Alcohol Related Pathology 833 843 .
Barbara A. Piasecki, James D. Lewis, K. Rajender Reddy, Scarlett L. Bellamy, Steven B. Porter, Robert M. Weinrieb, Donald D. Stieritz & Kyong-Mi Chang. (2004) Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40:4, pages 892-899.
Crossref
Barbara A. Piasecki, James D. Lewis, K. Rajender Reddy, Scarlett L. Bellamy, Steven B. Porter, Robert M. Weinrieb, Donald D. Stieritz & Kyong-Mi Chang. (2004) Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40:4, pages 892-899.
Crossref
Brian L. Pearlman. (2004) Hepatitis C treatment update. The American Journal of Medicine 117:5, pages 344-352.
Crossref
Alexander Monto. (2004) Alcohol and hepatitis C: Implications for disease progression and treatment. Current Hepatitis Reports 3:3, pages 105-111.
Crossref
Bin Gao, Feng Hong & Svetlana Radaeva. (2004) Host factors and failure of interferon-α treatment in hepatitis C virus. Hepatology 39:4, pages 880-890.
Crossref
Alexander Monto. (2003) Alcohol and hepatitis C: Implications for disease progression and treatment. Current Hepatitis Reports 2:3, pages 125-131.
Crossref
M.Mazen Jamal & Timothy R Morgan. (2003) Liver disease in alcohol and hepatitis C. Best Practice & Research Clinical Gastroenterology 17:4, pages 649-662.
Crossref
T Zhang. (2003) Alcohol potentiates hepatitis C virus replicon expression. Hepatology 38:1, pages 57-65.
Crossref
Marian Fireman. (2003) Hepatitis C Treatment and Substance Use Disorders. Psychiatric Annals 33:6, pages 402-408.
Crossref
Dinesh Kumar*Craig Wallington‐Beddoe*Jacob GeorgeRita LinDev SamarasingheChris LiddleGeoffrey C Farrell. (2003) Effectiveness of interferon alfa‐2b/ribavirin combination therapy for chronic hepatitis C in a clinic setting. Medical Journal of Australia 178:6, pages 267-271.
Crossref
Renuka Bhattacharya & Margaret C. Shuhart. (2003) Hepatitis C and Alcohol. Journal of Clinical Gastroenterology 36:3, pages 242-252.
Crossref
Marion G. Peters & Norah A. Terrault. (2002) Alcohol use and hepatitis C. Hepatology 36:5B, pages s220-s225.
Crossref
Marion G. Peters & Norah A. Terrault. (2002) Alcohol use and hepatitis C. Hepatology 36:S1, pages S220-S225.
Crossref
M. Tabone, L. Sidoli, C. Laudi, S. Pellegrino, G. Rocca, P. Della Monica, M. Fracchia, G. Galatola, G. C. Molinaro, S. Aricò & A. Pera. (2002) Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapy. Journal of Viral Hepatitis 9:4, pages 288-294.
Crossref
Bin Gao. (2002) Interaction of alcohol and hepatitis viral proteins. Alcohol 27:1, pages 69-72.
Crossref
Andrew J. Muir & Dawn Provenzale. (2002) A Descriptive Evaluation of Eligibility for Therapy Among Veterans With Chronic Hepatitis C Virus Infection. Journal of Clinical Gastroenterology 34:3, pages 268-271.
Crossref
Van-Anh Nguyen & Bin Gao. (2002) Expression of interferon alfa signaling components in human alcoholic liver disease. Hepatology 35:2, pages 425-432.
Crossref
Gyongyi Szabo, Donna Catalano, Gary Bellerose & Pranoti Mandrekar. (2001) Interferon alpha and Alcohol Augment Nuclear Regulatory Factor-kappaB Activation in HepG2 Cells, and Interferon alpha Increases Pro-Inflammatory Cytokine Production. Alcoholism: Clinical and Experimental Research 25:8, pages 1188-1197.
Crossref
Gyongyi Szabo, Donna Catalano, Gary Bellerose & Pranoti Mandrekar. (2001) Interferon ?? and Alcohol Augment Nuclear Regulatory Factor-??B Activation in HepG2 Cells, and Interferon ?? Increases Pro-Inflammatory Cytokine Production. Alcoholism: Clinical and Experimental Research 25:8, pages 1188-1197.
Crossref
Feng Hong, Van-Anh Nguyen & Bin Gao. (2001) Tumor necrosis factor α attenuates interferon‐α signaling in the liver: involvement of SOCS3 and SHP2 and implication in resistance to interferon therapy. The FASEB Journal 15:9, pages 1595-1597.
Crossref
Jianping Chen, Dahn L Clemens, Arthur I Cederbaum & Bin Gao. (2001) Ethanol inhibits the JAK-STAT signaling pathway in freshly isolated rat hepatocytes but not in cultured hepatocytes or HepG2 cells: evidence for a lack of involvement of ethanol metabolism. Clinical Biochemistry 34:3, pages 203-209.
Crossref
ROBERT W. HALEY & R. PAUL FISCHER. (2001) Commercial Tattooing as a Potentially Important Source of Hepatitis C Infection. Medicine 80:2, pages 134-151.
Crossref
Zhigang Tian, Xuening Shen, Hong Feng & Bin Gao. (2000) IL-1β Attenuates IFN-αβ-Induced Antiviral Activity and STAT1 Activation in the Liver: Involvement of Proteasome-Dependent Pathway. The Journal of Immunology 165:7, pages 3959-3965.
Crossref
Willis C. Maddrey. (2000) ALCOHOL-INDUCED LIVER DISEASE. Clinics in Liver Disease 4:1, pages 115-131.
Crossref
James Everhart & David Herion. 2000. Hepatitis C. Hepatitis C 363 388 .
Eugene R Schiff. (1999) The alcoholic patient with Hepatitis C Virus infection. The American Journal of Medicine 107:6, pages 95-99.
Crossref
Arie Regev & Lennox J. Jeffers. (1999) Hepatitis C and Alcohol. Alcoholism: Clinical and Experimental Research 23:9, pages 1543-1551.
Crossref
Françoise Degos. (1999) Hepatitis C and alcohol. Journal of Hepatology 31, pages 113-118.
Crossref
Christiane Bode, J. Christian Bode, Eckart G. Hahn, Siegbert Rossol, Christian Schäfer & Detlef Schuppan. 1999. Alkohol und Alkoholfolgekrankheiten. Alkohol und Alkoholfolgekrankheiten 226 269 .
Giulio Marchesini, Giampaolo Bianchi & Andrea Fabbri. (1998) LONG-TERM MANAGEMENT OF ALCOHOLIC LIVER DISEASE. Clinics in Liver Disease 2:4, pages 821-838.
Crossref
Mabee, Crippin & Lee. (1998) Review article: interferon and hepatitis C-factors predicting therapeutic outcome. Alimentary Pharmacology & Therapeutics 12:6, pages 509-518.
Crossref
Harumasa Yoshihara, Katsuhisa Noda & Takenobu Kamada. 1998. Recent Developments in Alcoholism. Recent Developments in Alcoholism 457 469 .
Satoshi Mochida, Kunihiko Ohnishi, Shuichi Matsuo, Kohji Kakihara & Kenji Fujiwara. (1996) Effect of Alcohol Intake on the Efficacy of Interferon Therapy in Patients with Chronic Hepatitis C as Evaluated by Multivariate Logistic Regression Analysis. Alcoholism: Clinical and Experimental Research 20:s9, pages 371A-377A.
Crossref
Shino SAKAI, Makoto WATANABE & Shiro FUKUMOTO. (2007) Laparoscopic Findings as a Predictor of the Efficacy of Interferon Therapy and Laparoscopic Changes in Sustained Responders after Interferon Therapy. Digestive Endoscopy 8:4, pages 293-301.
Crossref
M. Sata, K. Fukuizumi, Y. Uchimura, H. Nakano, K. Ishii, R. Kumashiro, M. Mizokami, J. Y. N. Lau & K. Tanikawa. (1996) Hepatitis C virus infection in patients with clinically diagnosed alcoholic liver diseases. Journal of Viral Hepatitis 3:3, pages 143-148.
Crossref
Katsuhisa Noda, Harumasa Yoshihara, Kunio Suzuki, Yukinori Yamada, Akinori Kasahara, Norio Hayashi, Hideyuki Fusamoto & Takenobu Kamada. (1996) Progression of Type C Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma-Its Relationship to Alcohol Drinking and the Age of Transfusion. Alcoholism: Clinical and Experimental Research 20:s1, pages 95a-100a.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.